Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Adaptive NK cell reconstitution is associated with better clinical outcomes.

Cichocki F, Taras E, Chiuppesi F, Wagner JE, Blazar BR, Brunstein C, Luo X, Diamond DJ, Cooley S, Weisdorf DJ, Miller JS.

JCI Insight. 2019 Jan 24;4(2). pii: 125553. doi: 10.1172/jci.insight.125553. [Epub ahead of print]

2.

ARID5B regulates metabolic programming in human adaptive NK cells.

Cichocki F, Wu CY, Zhang B, Felices M, Tesi B, Tuininga K, Dougherty P, Taras E, Hinderlie P, Blazar BR, Bryceson YT, Miller JS.

J Exp Med. 2018 Sep 3;215(9):2379-2395. doi: 10.1084/jem.20172168. Epub 2018 Jul 30.

PMID:
30061358
3.

Adaptive NK Cells Resist Regulatory T-cell Suppression Driven by IL37.

Sarhan D, Hippen KL, Lemire A, Hying S, Luo X, Lenvik T, Curtsinger J, Davis Z, Zhang B, Cooley S, Cichocki F, Blazar BR, Miller JS.

Cancer Immunol Res. 2018 Jul;6(7):766-775. doi: 10.1158/2326-6066.CIR-17-0498. Epub 2018 May 21.

PMID:
29784636
4.

Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.

Burrack KS, Huggins MA, Taras E, Dougherty P, Henzler CM, Yang R, Alter S, Jeng EK, Wong HC, Felices M, Cichocki F, Miller JS, Hart GT, Johnson AJ, Jameson SC, Hamilton SE.

Immunity. 2018 Apr 17;48(4):760-772.e4. doi: 10.1016/j.immuni.2018.03.012. Epub 2018 Apr 3.

PMID:
29625893
5.

GSK3 Inhibition Drives Maturation of NK Cells and Enhances Their Antitumor Activity.

Cichocki F, Valamehr B, Bjordahl R, Zhang B, Rezner B, Rogers P, Gaidarova S, Moreno S, Tuininga K, Dougherty P, McCullar V, Howard P, Sarhan D, Taras E, Schlums H, Abbot S, Shoemaker D, Bryceson YT, Blazar BR, Wolchko S, Cooley S, Miller JS.

Cancer Res. 2017 Oct 15;77(20):5664-5675. doi: 10.1158/0008-5472.CAN-17-0799. Epub 2017 Aug 8.

6.

Correction: Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells.

Freund J, May RM, Yang E, Li H, McCullen M, Zhang B, Lenvik T, Cichocki F, Anderson SK, Kambayashi T.

PLoS Biol. 2016 Dec 29;14(12):e1002590. doi: 10.1371/journal.pbio.1002590. eCollection 2016 Dec.

7.

Adaptive NK Cells with Low TIGIT Expression Are Inherently Resistant to Myeloid-Derived Suppressor Cells.

Sarhan D, Cichocki F, Zhang B, Yingst A, Spellman SR, Cooley S, Verneris MR, Blazar BR, Miller JS.

Cancer Res. 2016 Oct 1;76(19):5696-5706. Epub 2016 Aug 8.

8.

Activating Receptor Signals Drive Receptor Diversity in Developing Natural Killer Cells.

Freund J, May RM, Yang E, Li H, McCullen M, Zhang B, Lenvik T, Cichocki F, Anderson SK, Kambayashi T.

PLoS Biol. 2016 Aug 8;14(8):e1002526. doi: 10.1371/journal.pbio.1002526. eCollection 2016 Aug. Erratum in: PLoS Biol. 2016 Dec 29;14 (12 ):e1002590.

9.

Epigenetic Regulation of Adaptive NK Cell Diversification.

Tesi B, Schlums H, Cichocki F, Bryceson YT.

Trends Immunol. 2016 Jul;37(7):451-461. doi: 10.1016/j.it.2016.04.006. Epub 2016 May 6. Review.

PMID:
27160662
10.

Near zerO fluoroscopic exPosure during catheter ablAtion of supRavenTricular arrhYthmias: the NO-PARTY multicentre randomized trial.

Casella M, Dello Russo A, Pelargonio G, Del Greco M, Zingarini G, Piacenti M, Di Cori A, Casula V, Marini M, Pizzamiglio F, Zucchetti M, Riva S, Russo E, Narducci ML, Soldati E, Panchetti L, Startari U, Bencardino G, Perna F, Santangeli P, Di Biase L, Cichocki F, Fattore G, Bongiorni M, Picano E, Natale A, Tondo C.

Europace. 2016 Oct;18(10):1565-1572. Epub 2015 Nov 10.

11.

UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.

Iizuka Y, Cichocki F, Sieben A, Sforza F, Karim R, Coughlin K, Isaksson Vogel R, Gavioli R, McCullar V, Lenvik T, Lee M, Miller J, Bazzaro M.

J Immunol. 2015 Nov 15;195(10):4760-70. doi: 10.4049/jimmunol.1500979. Epub 2015 Oct 5.

12.

CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.

Cichocki F, Cooley S, Davis Z, DeFor TE, Schlums H, Zhang B, Brunstein CG, Blazar BR, Wagner J, Diamond DJ, Verneris MR, Bryceson YT, Weisdorf DJ, Miller JS.

Leukemia. 2016 Feb;30(2):456-63. doi: 10.1038/leu.2015.260. Epub 2015 Sep 29.

13.

Successful treatment of mast cell activation syndrome with sunitinib.

Afrin LB, Cichocki FM, Patel K, Molderings GJ.

Eur J Haematol. 2015 Dec;95(6):595-7. doi: 10.1111/ejh.12606. Epub 2015 Jun 25.

PMID:
26072665
14.

Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation.

Davis ZB, Cooley SA, Cichocki F, Felices M, Wangen R, Luo X, DeFor TE, Bryceson YT, Diamond DJ, Brunstein C, Blazar BR, Wagner JE, Weisdorf DJ, Horowitz A, Guethlein LA, Parham P, Verneris MR, Miller JS.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1653-62. doi: 10.1016/j.bbmt.2015.05.025. Epub 2015 Jun 6.

15.

The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.

Cichocki F, Verneris MR, Cooley S, Bachanova V, Brunstein CG, Blazar BR, Wagner J, Schlums H, Bryceson YT, Weisdorf DJ, Miller JS.

Curr Top Microbiol Immunol. 2016;395:225-43. doi: 10.1007/82_2015_445. Review.

16.

Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function.

Schlums H, Cichocki F, Tesi B, Theorell J, Beziat V, Holmes TD, Han H, Chiang SC, Foley B, Mattsson K, Larsson S, Schaffer M, Malmberg KJ, Ljunggren HG, Miller JS, Bryceson YT.

Immunity. 2015 Mar 17;42(3):443-56. doi: 10.1016/j.immuni.2015.02.008.

17.

Human natural killer cell microRNA: differential expression of MIR181A1B1 and MIR181A2B2 genes encoding identical mature microRNAs.

Presnell SR, Al-Attar A, Cichocki F, Miller JS, Lutz CT.

Genes Immun. 2015 Jan-Feb;16(1):89-98. doi: 10.1038/gene.2014.65. Epub 2014 Nov 20.

18.

Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.

Cichocki F, Schlums H, Li H, Stache V, Holmes T, Lenvik TR, Chiang SC, Miller JS, Meeths M, Anderson SK, Bryceson YT.

J Exp Med. 2014 Jun 2;211(6):1079-91. doi: 10.1084/jem.20131131. Epub 2014 May 19.

19.

NK cell development and function--plasticity and redundancy unleashed.

Cichocki F, Sitnicka E, Bryceson YT.

Semin Immunol. 2014 Apr;26(2):114-26. doi: 10.1016/j.smim.2014.02.003. Epub 2014 Mar 1. Review.

PMID:
24594002
20.

The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).

Foley B, Felices M, Cichocki F, Cooley S, Verneris MR, Miller JS.

Immunol Rev. 2014 Mar;258(1):45-63. doi: 10.1111/imr.12157. Review.

21.

Identification of a KIR antisense lncRNA expressed by progenitor cells.

Wright PW, Huehn A, Cichocki F, Li H, Sharma N, Dang H, Lenvik TR, Woll P, Kaufman D, Miller JS, Anderson SK.

Genes Immun. 2013 Oct;14(7):427-33. doi: 10.1038/gene.2013.36. Epub 2013 Jul 18.

22.

Epigenetic regulation of NK cell differentiation and effector functions.

Cichocki F, Miller JS, Anderson SK, Bryceson YT.

Front Immunol. 2013 Feb 28;4:55. doi: 10.3389/fimmu.2013.00055. eCollection 2013.

23.

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ.

Blood. 2012 Oct 25;120(17):3455-65. doi: 10.1182/blood-2012-03-416867. Epub 2012 Sep 11.

24.

Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.

Gleason MK, Lenvik TR, McCullar V, Felices M, O'Brien MS, Cooley SA, Verneris MR, Cichocki F, Holman CJ, Panoskaltsis-Mortari A, Niki T, Hirashima M, Blazar BR, Miller JS.

Blood. 2012 Mar 29;119(13):3064-72. doi: 10.1182/blood-2011-06-360321. Epub 2012 Feb 8.

25.

Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Cichocki F, Felices M, McCullar V, Presnell SR, Al-Attar A, Lutz CT, Miller JS.

J Immunol. 2011 Dec 15;187(12):6171-5. doi: 10.4049/jimmunol.1100835. Epub 2011 Nov 14.

26.

Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters.

Cichocki F, Miller JS, Anderson SK.

J Innate Immun. 2011;3(3):242-8. doi: 10.1159/000323929. Epub 2011 Mar 11. Review.

27.

Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells.

Cichocki F, Lenvik T, Sharma N, Yun G, Anderson SK, Miller JS.

J Immunol. 2010 Aug 15;185(4):2009-12. doi: 10.4049/jimmunol.1000855. Epub 2010 Jul 14.

28.

Tungsten-rhenium suture needles with improved properties for coronary artery bypass graft surgery.

Cichocki FR Jr, Maurer RE, Bar SN.

J Biomed Mater Res B Appl Biomater. 2010 Aug;94(2):493-500. doi: 10.1002/jbm.b.31661. Review.

PMID:
20574974
29.

In vitro development of human Killer-Immunoglobulin Receptor-positive NK cells.

Cichocki F, Miller JS.

Methods Mol Biol. 2010;612:15-26. doi: 10.1007/978-1-60761-362-6_2.

PMID:
20033631
30.

The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.

Cichocki F, Hanson RJ, Lenvik T, Pitt M, McCullar V, Li H, Anderson SK, Miller JS.

Blood. 2009 Apr 2;113(14):3245-53. doi: 10.1182/blood-2008-07-166389. Epub 2008 Nov 5.

31.

A bioabsorbable microcatheter for the continuous and direct treatment of surgical sites.

Cichocki FR Jr, Barbolt TA, Savidge SJ, Chen G, Zhou J.

J Biomater Appl. 2007 Sep;22(2):145-62. Epub 2006 Oct 25.

PMID:
17065162
32.

First trimester maternal thyroid X-ray exposure and neonatal birth weight.

De Santis M, Straface G, Cavaliere AF, Caruso A, Cichocki F, Venga L, Mastroiacovo P.

Reprod Toxicol. 2005 May-Jun;20(1):3-4. No abstract available.

PMID:
15808780
33.

[Determination of computer tomography dose index by means of ion chamber measurements].

Piermattei A, Cichocki F, Rossi G, Venga L, Arcovito G.

Radiol Med. 1995 Jan-Feb;89(1-2):151-4. Italian.

PMID:
7716297
34.

[Evaluation of the absorbed dosage in Compton tomography].

Arcovito G, Azario L, Cichocki F, Piermattei A, Rossi G, Galli G.

Radiol Med. 1989 May;77(5):540-3. Italian.

PMID:
2748967

Supplemental Content

Loading ...
Support Center